PRODUCTION OF LEUKEMIA-REACTIVE T-CELLS VIA A GOOD MANUFACTURING PRACTICE PROCEDURE FOR TREATMENT OF PATIENTS WITH ACUTE OR CHRONIC B-CELL MALIGNANCIES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION